CSTL
Castle Biosciences Inc
36.70$
+3.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.2% | 28.1% | -9.4% | 27.6% | 27.2% | 28.2% | -6.9% | 24.2% | 27.3% | 31.0% | -26.4% | 14.7% | 11.9% | |
| 5.2% | 4.9% | 4.6% | 3.8% | 4.1% | 6.7% | 33.8% | 4.0% | 4.6% | 4.3% | 4.7% | 3.9% | 4.4% | |
| 21.2% | 17.8% | 17.4% | 15.1% | 15.2% | 13.3% | 12.7% | 13.0% | 14.6% | 13.1% | 11.7% | 11.2% | 12.6% | |
| -4.6% | 11.6% | -25.8% | 2.2% | 0.9% | 2.3% | -23.2% | 9.9% | 13.9% | 16.1% | -23.1% | 1.1% | 2.0% | |
| 4.0% | 5.7% | 12.5% | 6.0% | 7.4% | 8.8% | 5.4% | 10.7% | 17.9% | 8.3% | 14.9% | 8.4% | 12.1% | |
| -15.8% | -11.6% | -27.0% | -24.6% | -17.2% | 6.7% | -25.5% | -32.9% | -22.1% | 10.1% | -30.8% | -15.4% | -14.4% | |
| 0.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.4% | -6.1% | -0.6% | -0.7% | 1.3% | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 0.1% | -5.0% | 14.6% | 0.0% | 1.0% | -6.2% | -1.8% | 0.1% | -1.1% | -5.3% | -6.0% | -0.9% | -3.2% | |
| -7.6% | 11.5% | -21.8% | 3.0% | 10.9% | 28.7% | -34.1% | -8.7% | 4.0% | 35.8% | -63.3% | -1.6% | -5.6% | |
| 4.2% | 22.4% | -21.9% | 21.6% | 19.8% | 19.5% | -12.2% | 13.4% | 9.4% | 22.7% | -41.3% | 6.3% | -0.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.